Literature DB >> 6475790

Thallium-201 accumulation during reperfusion of ischemic myocardium: dependence on regional blood flow rather than viability.

R Forman, E S Kirk.   

Abstract

These experiments in dogs were designed to determine whether the use of thallium 201 (TI-201) accumulation in patients during the reperfusion phase after streptokinase lysis of an intracoronary thrombus is a function of coronary blood flow or a function of myocardial viability. The left anterior descending coronary artery was occluded for 60 minutes in open-chest dogs, and the immediate TI-201 accumulation and regional blood flow (MBF) using microspheres was measured in 2 groups: 10 minutes after reperfusion in 9 dogs (group A) and 24 hours after reperfusion in 6 dogs (group B). There was an 80% or greater reduction in MBF in the subendocardium during ischemia in both groups of dogs, and it was inferred that the subendocardium was destined to become necrotic in group A and had become necrotic in group B dogs. The ratio of TI-201 accumulation to MBF in the tissue that had been ischemic was not significantly different from the ratio in normal tissue despite MBF being in the normal range in group A (n = 7, 2 dogs excluded because of reactive hyperemia) and being markedly decreased in group B. Thus, the immediate TI-201 distribution was related to MBF, and caution is recommended in its use to assess myocardial salvage in the early reperfusion phase after streptokinase lysis of intracoronary thrombi. These data suggest that the intramyocardial accumulation of TI-201 is predominantly a passive process and independent of Na-K ATPase.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6475790     DOI: 10.1016/0002-9149(84)90268-6

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  11 in total

1.  Reverse redistribution on Tl-201 SPECT images after reperfusion therapy for acute myocardial infarction: possible mechanism and prognostic implications.

Authors:  S Fukuzawa; S Ozawa; M Nobuyoshi; Y Inagaki
Journal:  Heart Vessels       Date:  1992       Impact factor: 2.037

2.  Assessment of Regional Viability in the Infarct Zone Following Myocardial Infarction.

Authors: 
Journal:  J Thromb Thrombolysis       Date:  1997       Impact factor: 2.300

3.  PET reflections.

Authors:  U Buell
Journal:  Eur J Nucl Med       Date:  1991

4.  Clinical significance of 201Tl reverse redistribution in patients with aorto-coronary bypass surgery.

Authors:  T Nishimura; T Uehara; K Hayashida; T Kozuka
Journal:  Eur J Nucl Med       Date:  1987

Review 5.  Role of single photon wall motion and perfusion studies in the evaluation of patients with suspected coronary artery disease.

Authors:  H Yaoita; H W Strauss
Journal:  Eur J Nucl Med       Date:  1990

6.  Assessment of non-reperfused and reperfused myocardial infarction using diffusible or deposited radiolabelled perfusion imaging agents.

Authors:  L M Riou; A Broisat; C Lartizien; M C Toufektsian; S Maitrejean; M Janier; G Vanzetto; D Fagret; C Ghezzi
Journal:  Eur J Nucl Med Mol Imaging       Date:  2006-09-27       Impact factor: 9.236

7.  Defect reversibility using thallium-201 reinjection. Comparison of stress-redistribution-reinjection with stress-immediate reinjection.

Authors:  B L van Eck-Smit; A F Kuijper; A H Zwinderman; A V Bruschke; E K Pauwels; E E van der Wall
Journal:  Int J Card Imaging       Date:  1996-03

8.  Comparison of thallium-201 single-photon emission tomography after rest injection and fluorodeoxyglucose positron emission tomography for assessment of myocardial viability in patients with chronic coronary artery disease.

Authors:  C Altehoefer; J vom Dahl; U Buell; R Uebis; E Kleinhans; P Hanrath
Journal:  Eur J Nucl Med       Date:  1994-01

9.  Evaluation of cellular viability by quantitative autoradiographic study of myocardial uptake of a fatty acid analogue in isoproterenol-induced focal rat heart necrosis.

Authors:  T Humbert; C Luu-Duc; M Comet; P Demenge
Journal:  Eur J Nucl Med       Date:  1991

10.  Teboroxime is a marker of reperfusion after myocardial infarction.

Authors:  L I Heller; B J Villegas; C P Reinhardt; S T Dahlberg; R Marcel; J A Leppo
Journal:  J Nucl Cardiol       Date:  1996 Jan-Feb       Impact factor: 5.952

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.